Key facts
- TYBR Health’s last known valuation is $16.8M (Nov 2025).
- It has raised $8.7M across 2 recorded rounds; the latest was Early Stage VC ($7.1M) in Jan 2025.
- Notable investors include Plug and Play Tech Center, Y Combinator, Creative Destruction Lab, MedTech Innovator, Texas Medical Center — 13 tracked in total.
- TYBR Health has filed 2 Form Ds with the SEC since 2020, most recently Jan 2025 ($1.1M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for TYBR Health
Funding rounds
2 roundsAbout TYBR Health
Developer of a collagen-based resorbable hydrogel designed to protect healing tendons and ligaments and support recovery after surgery. The company offers a gel delivered through a proprietary applicator that is compatible with open and minimally invasive procedures, creating a protective barrier at the repair site, enabling clinicians to reduce complications that can impair tissue function.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2020
- Employees
- 4
- Website
- tybrhealth.com/
- Ownership
- Privately Held (backing)
TYBR Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TYBR Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TYBR Health in its N-PORT filings yet. We sweep new filings monthly.